ARTICLE | Strategy
Let a thousand ideas bloom
How Shire is breaking the mold to fuel external discovery in rare diseases
May 20, 2013 7:00 AM UTC
Shire plc has long been a growth through acquisition company, but the pace of its external discovery is picking up steam and the company now has over 20 ongoing projects to show for it.
Traditional research collaborations are target- or MOA-driven, with the pharma or biotech supporting academic institutions that have a program focused on a particular disease-related gene or a novel disease pathway...